Renal Cancer - Results from #2080

Clinical Effectiveness of Second-line Sunitinib Following Immuno-oncology Therapy in Patients with Metastatic Renal Cell Carcinoma: A Real-world Study. April 19, 2021

Identification and validation of the clinical roles of the VHL-related LncRNAs in clear cell renal cell carcinoma. April 19, 2021

Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacy. April 19, 2021

A comparison of oncologic and functional outcomes in patients with pt3a renal cell carcinoma treated with partial and radical nephrectomy. April 16, 2021

Pattern, timing and predictors of recurrence after surgical resection of chromophobe renal cell carcinoma. April 16, 2021

Outcomes of Artificial Intelligence Volumetric Assessment of Kidneys and Renal Tumors for Preoperative Assessment of Nephron Sparing Interventions. April 15, 2021

A psychometric evaluation of the Functional assessment of cancer therapy-kidney symptom index (FKSI-19) among renal cell carcinoma patients suggesting an alternative two-factor structure. April 15, 2021

Metabolic imaging with hyperpolarized 13 C pyruvate magnetic resonance imaging in patients with renal tumors-Initial experience. April 14, 2021

Prognostic and therapeutic implications of extracellular matrix associated gene signature in renal clear cell carcinoma. April 14, 2021

JNCCN Study Finds Important Potential Role for Routine Brain Imaging in Advanced Kidney Cancer April 13, 2021

Irreversible electroporation (IRE) in renal cell carcinoma (RCC): a mid-term clinical experience. April 13, 2021

A Living, Interactive Systematic Review and Network Meta-analysis of First-line Treatment of Metastatic Renal Cell Carcinoma. April 13, 2021

Prognosis of Incidental Brain Metastases in Patients With Advanced Renal Cell Carcinoma. April 13, 2021

Clinical Results and Biomarker Analyses of Axitinib and TRC105 versus Axitinib Alone in Patients with Advanced or Metastatic Renal Cell Carcinoma (TRAXAR). April 12, 2021

Plasma KIM-1 is associated with recurrence risk after nephrectomy for localized renal cell carcinoma: A trial of the ECOG-ACRIN Research Group (E2805). April 12, 2021

A challenging frontier - the genomics and therapeutics of nonclear cell renal cell carcinoma. April 9, 2021

Clinical Features and Multiplatform Molecular Analysis Assist in Understanding Patient Response to Anti-PD-1/PD-L1 in Renal Cell Carcinoma. April 9, 2021

3D-Image guided robotic-assisted partial nephrectomy: a multi-institutional propensity score-matched analysis (UroCCR study 51). April 8, 2021

Urinary Volatilomics Unveils a Candidate Biomarker Panel for Noninvasive Detection of Clear Cell Renal Cell Carcinoma. April 8, 2021

Subgroup-Independent Mapping of Renal Cell Carcinoma-Machine Learning Reveals Prognostic Mitochondrial Gene Signature Beyond Histopathologic Boundaries. April 7, 2021

Page 105 of 456